Brain infusions from younger mice revive memory in older ones

Cerebrospinal fluid transfusions demonstrate a potential path to treating cognitive decline

Stanford researchers have found that they can improve the memory of older mice by infusing cerebrospinal fluid (CSF) of younger ones into their brains — a strange but fascinating discovery that may eventually lead to ways to limit the cognitive damage of aging.

The painstaking experiment, published in Nature, showed that the infusion impacted brain cells called “oligodendrocytes.”

“These are the cells that basically make the insulation over the wiring between nerve cells in the brain — it’s like the plastic cover over a cable,” Stanford neurologist Tony Wyss-Coray told STAT

That insulation, called myelin, is key to the cells communicating effectively, and young CSF caused the older mice to produce more of these cells for better insulation.

“This is a very cool study that looks scientifically solid to me,” University of Washington aging researcher Matt Kaeberlein, who was not involved in the study, told the New York Times. “This adds to the growing body of evidence that it’s possible, perhaps surprisingly easy, to restore function in aged tissues by targeting the mechanisms of biological aging.”

Cerebrospinal fluid (CSF) provides nutrients and a layer of protection to the brain and spinal cord.

Brain soup: The brain and spinal cord are full of CSF, which provides a layer of protection to these critical organs and nutrients for the nerve cells. Testing CSF can be used to help diagnose some neurological conditions, but we still have a lot to learn.

“The field has lagged decades behind other areas of neuroscience,” Boston Children’s Hospital CSF researcher Maria Lehtinen told the NYT. “Largely this is because of the technical limitations in studying a fluid that’s deep inside the brain, and that turns over continuously.” 

Lehtinen wrote an article accompanying the study for Nature.

Harvesting that CSF for infusion was a daunting challenge. It required extracting tiny, tiny droplets of fluid from hundreds of mice, a painstaking process that took Stanford neuroscientist Tal Iram a full year, Nature reported.

To infuse it into the older mice, Iram implanted a tiny pump on their backs, which slowly fed the fluid into their brains over the course of several days to avoid increasing the pressure in their brains.

The researchers found that they can improve the memory of older mice by infusing the CSF of younger ones into their brains.

Signs of improvement: To test whether the CSF made an impact on memory, the researcher first needed to form a clear memory that could be tested. They gave small electric shocks to the feet of 20-month-old-mice in combination with flashes of light and sound, Nature reported. 

This formed an association between the lights and sounds with a shock, even if the shock didn’t come, so that the mice would freeze instinctively when the lights and sounds happened. 

Young mice would remember such an experience for weeks, Wyss-Coray told NPR. “When they’re old, they keep forgetting about this. A few days later, they can’t remember that they were in a bad environment.”

The team infused the young CSF into 8 aging mice, with 10 control mice receiving a placebo. After three weeks, the mice were exposed to the light and sound without the shock. The mice who had received the CSF froze up almost 40% of the time, reflecting a memory of the shock, while the control mice only froze 18% of the time, Nature reported.

By analyzing the CSF and its impact on the nerve-insulating oligodendrocytes, the team picked out one protein in particular that seemed to have an impact, called Fgf17.

When mice received infusions of just Fgf17, they showed a similar improvement in memory, and antibodies designed to block the protein had a detrimental effect on memory, making them less successful in a maze test, STAT reported.

Their study suggests that CSF is an “active” fluid, capable of rejuvenating the brain, Wyss-Cory told STAT. “So it’s a source of entirely new biology that people have only just begun to pursue.”

While fascinating, the research is still likely years away from leading to human treatments.

A long way from humans: As always in medical science, however, it’s important to note mice can lie. Many a mouse has been cured of cancer or Alzheimer’s, with the resulting effects failing to show up in people. 

The difficulty of extracting CSF is probably an insurmountable obstacle to clinical use, Buck Institute for Research on Aging scientist Julie Andersen told Nature; it would be invasive, and other potential impacts are unknown.

However, an artificial form of Fgf17 may be a more likely therapeutic, Wyss-Cory told STAT, although such a thing would still require years of development. 

“In general, people are looking for the Holy Grail of aging, and they think there is going to be a magical factor that’s being secreted that’s just going to reverse this thing,” Mount Sinai Medical Center biochemist Jeffrey Haines, who was not involved in the study, told the NYT.

“I don’t think it’s that simple.”

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at tips@freethink.com.

Related
A protein found in human sweat may protect against Lyme disease
Human sweat contains a protein that may protect against Lyme disease, according to a study from MIT and the University of Helsinki.
Pacemaker powered by light eliminates need for batteries and lets the heart to function more naturally
Scientists designed a pacemaker that transforms light into bioelectricity, or heart cell-generated electrical signals.
Generative AI tech is dreaming up new antibodies
A new tool for designing antibodies relies on the same kind of tech underpinning DALL-E and other image-generating AIs.
Pill to prevent Lyme disease kills ticks before they can infect you
A pill to prevent Lyme disease quickly killed ticks that bit treated volunteers, suggesting it could slow the spread of tick-borne diseases.
Drugs made in space “cooked real good,” says startup
Varda Space Industries has shared the results of its first mission to manufacture “space drugs” in Earth’s orbit.
Up Next
Exit mobile version